Back to Entrepreneur Of The Year

Meet the 2025 New England winners

Congratulations to the Entrepreneur Of The Year® 2025 New England winners, the shapers of our future! These innovators are boldly disrupting markets, revolutionizing industries, and transforming lives, paving the way for a brighter tomorrow! 

Learn more about our winners

Errik Anderson | Alloy Therapeutics | Waltham, Massachusetts

Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners spanning academia, biotech, and the largest biopharma companies, Alloy democratizes access to pre-competitive tools, technologies, services, and company creation capabilities foundational for discovering and developing therapeutic biologics across six modalities: antibodies, TCRs, RNA medicines, peptides, cell therapies, and drug delivery. Partners may access all current and future technologies either through a discovery service relationship or for a flat annual fee via Alloy’s Innovation Subscriptions offering. As a reflection of Alloy’s relentless commitment to the scientific community, it reinvests 100% of its revenue in innovation and in facilitating access to innovation.

back to the top

John V. Oyler | BeOne Medicines | Cambridge, Massachusetts

John is the Co-Founder, Chairman and CEO of BeOne Medicines.

BeOne Medicines is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 11,000 colleagues spans six continents.

back to the top

Claire Mazumdar | Bicara Therapeutics | Boston, Massachusetts

Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Our lead program, ficerafusp alfa, is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-β). Through this dual-targeting mechanism, ficerafusp alfa has the potential to exert potent anti-tumor activity by simultaneously blocking both cancer cell-intrinsic EGFR survival and proliferation, as well as the immunosuppressive TGF-β signaling within the tumor microenvironment. Ficerafusp alfa is initially being developed in head and neck squamous cell carcinoma, where there remains a significant unmet need.

back to the top

Kate Haviland | Blueprint Medicines | Cambridge, Massachusetts

Blueprint Medicines is a global biopharmaceutical company that invents life-changing medicines. We seek to improve and extend patients' lives by solving important medical problems, with a focus on allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

back to the top

Nabiha Saklayen | Cellino Biotech | Cambridge, Massachusetts

Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacements for patients. Cellino’s technology leverages AI co-pilots and a laser-based cell management process to automate the artisanal manufacturing of induced pluripotent stem cells (iPSCs), which can be differentiated into any cell type in the body. This enables the development of disease-reversing and potentially curative therapies for a range of chronic degenerative conditions, including diabetes, heart disease, obesity, and Parkinson’s. The company’s vision is to transform medicine to enhance healthy lifespan for billions of people across generations.

back to the top

Siva Namasivayam | Cohere Health | Boston, Massachusetts

Prior authorization (PA) is a complex, often manual process to show that care is medically appropriate and to ultimately improve patient outcomes. Frustrations often arise around PA-associated care delays and admin burden; in an annual AMA PA survey, 93% of physicians reported care delays associated with PA. For innovative health plans seeking to improve PA, intelligent prior authorization solutions can help. By automating and simplifying outdated processes, these solutions can support health plans’ efforts to improve care quality and costs. Cohere’s platform goes beyond approving or denying authorization requests. Using AI/ML, predictive analytics, and robust clinical expertise, we help providers deliver more personalized, efficient care. Intelligent prior authorizations enable health plans to move away from transactional processes and toward a more comprehensive, valuable approach that improves care and outcomes and creates a better PA process. Cohere is unique in offering both a licensed platform-as-a-service (PaaS) intelligent PA solution and a fully delegated utilization management (UM) solution, which offer health plans the flexibility to support in-house processes and/or outsource UM operations for specific specialties.

back to the top

Jeff Elton | ConcertAI | Cambridge, Massachusetts

ConcertAI is the leader in predictive and generative AI SaaS and real-world data solutions, transforming healthcare and life sciences. Focused on optimizing oncology care through data-driven insights, ConcertAI provides advanced solutions that power clinical decision-making, accelerate research, and improve cancer patient outcomes. Its offerings include CARAai™, a multi-modal data management, predictive and generative AI platform that accelerates research and enables AI-driven workflows; TeraRecon Oncology Suite, an AI-diagnostic toolset enhancing early cancer detection and accurate diagnosis; CancerLinq, a network of leading cancer centers dedicated to quality and research, providing real-world oncology insights; and its Digital Trial Solution, an AI platform improving clinical trial screening and patient matching, increasing trial accessibility and effectiveness. Serving oncology, hematology, biotech, AI, and medical imaging markets, ConcertAI delivers AI-powered and real-world data services and solutions, driving innovation in AI and healthcare. Its commitment to technological and medical excellence has led to partnerships with NVIDIA, NeoGenomics, and DeepHealth, uniting AI and healthcare leaders to build next-gen solutions.

back to the top

Carlos Ventura | Feast & Fettle | East Providence, Rhode Island

At Feast & Fettle, we are on a mission to bring joy and connection back to the table. We understand the choice you face when it comes to mealtime: spend hours planning and cooking to feed your family well or settle for takeout or something overly processed to save precious time. So, we started Feast & Fettle to make it easier for families to enjoy quality meals together. Our chefs create wholesome, homemade meals using fresh produce, recognizable ingredients, and the same care as you would in your own kitchen. From there, each meal is sustainably packaged and delivered to your doorstep by our team. Our promise is simple: a full-service hospitality experience that supports you, so you can spend time doing the things you love with the ones you love most. This promise is in everything we do, from supporting our team members in and beyond the workplace, to giving back to the communities we serve. Because food is so much more than calories, it’s nourishment. It brings warmth, comfort, and connection. And nothing is more powerful than a shared meal.

back to the top

Joanne Chang | Flour Bakery + Cafe | Boston, Massachusetts

Flour is a bakery and cafe with 9 (soon 10) locations in the Boston area. We offer amazing food, warm welcoming service, and a commitment to making everyone who comes into Flour leave happier than when they walked in. We offer breakfast pastries, cookies, cakes, pies, breads, pizzas, sandwiches, salads, soups, and homemade seltzers. We pride ourselves on making everything in house. 

back to the top

Yogesh Gupta | Progress Software | Burlington, Massachusetts

Progress (Nasdaq: PRGS) empowers organizations to achieve transformational success in the face of disruptive change. Our software enables our customers to develop, deploy and manage responsible, AI-powered applications and experiences with agility and ease. Customers get a trusted provider in Progress, with the products, expertise and vision they need to succeed. Over 4 million developers and technologists at hundreds of thousands of enterprises depend on Progress.

back to the top

Krenar Komoni | Tive | Boston, Massachusetts

Tive is the global leader in supply chain and logistics visibility technology. More than 950 global shippers, logistics service providers, and retailers use Tive to monitor shipment location and condition in real time, gain actionable insights, and ensure end-customer satisfaction. Tive's cloud platform, patented sensor technology, and 24/7 Live Monitoring services reduce excursions and delays, minimize rejected loads, and decrease theft, damage, and spoilage. Tive's Green Program reduces electronic waste by renewing and recirculating trackers and extending their life. Customers count on Tive to ensure that shipments are delivered on time and in full—because every shipment matters.

back to the top

Kevin McCarthy | Unreal Brands | Boston, Massachusetts

UNREAL is a mission-based brand that is creating the new reality of what candy can be. UNREAL is reinventing iconic candy products - such as Peanut Butter Cups, Coconut Bars, Candy Coated Chocolate Gems and Caramel Peanut Nougat Bars - with simple, real ingredients, way less sugar and, importantly, truly incredible taste, unlocking the joy, fun and shareability in this impactful and meaningful category. UNREAL is leading the charge to bring energy and growth to this aisle in the grocery store - offering consumers a better choice that is not burdened by harmful dyes, excess sugar and artificial ingredients. UNREAL is a leading brand in the better-for-you confection category, growing rapidly over the past several years in a purposeful and sustainable way. UNREAL is inviting consumers back to the candy aisle, growing the size of the total category and setting it up for long term success and growth. The brand continues to accelerate its growth through exciting new product launches, new distribution gains to serve more consumers and by continuing to meet the needs of its core consumers today. UNREAL products can be found nationwide in all major retailers including Target, Walmart, Costco, Whole Foods Market, Kroger and Publix.

back to the top